Material Insights · Understanding the Material World

Insulin medicines: Bill of materials

About these figures

Which unit, study and year the composition figures describe, and how they vary

No source opened gives the make-up of a vial or pen in grams. The active ingredient is a peptide made by microbes [6]. The medicine is sold as a solution or suspension in vials and cartridges [7] or in plastic pre-filled pens with glass inside [16]; no source opened lists the other ingredients. The pen body and the glass container are not yet product nodes. Stages are named only; no process conditions, strains or recipes are given.

as of 2026-11-13

Direct materials

The commodities and chemicals in one unit as bought, with amount, mass share, cost share and recycled content

MaterialRoleAmount in one unitShare of the unit's mass
Pep Peptides and oligonucleotidesFunctionalNot given –
The active ingredient, insulin, is a peptide made recombinantly by microbes [6]; no source opened gives the mass per vial or pen.

as of 2026-11-13

How it is put together

The main steps from parts and materials to the finished unit

StepWhat happensTechnologySource
Recombinant productionYeast, or E. coli in the bacterial route, carrying the human gene make an insulin precursorRecombinant DNA (genetic engineering)[6]
ConversionAn enzyme turns the precursor into human insulin; the E. coli route has an extra refolding stage– [6]
Chemical modificationFor some analogues a fatty acid is attached to the insulin– [6]
Formulation and fillingThe insulin is formulated and filled into cartridges and pre-filled pens, or into vials– [17][7]

as of 2026-11-13

Technologies used to make it

The technologies used to make it, at which step

Made with
  • rDNA Recombinant DNA (genetic engineering) Recombinant production of the insulin precursor Humulin, approved by the FDA in 1982, was made by bacteria and was the first FDA-approved recombinant drug of any kind [3]; no share of output made this way was found.

as of 2026-11-13

Sources

  1. Insulin Development and Commercialization American Chemical Society (National Historic Chemical Landmark), 2023, landmark booklet, © 2023 American Chemical Society
  2. Insulin: Recombinant Production, Sustainability, and Chemistry Oxford Global (article by Tom Cohen on a presentation by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk), 2023, page of 25 April 2023
  3. First human insulins prequalified World Health Organization, Prequalification of Medical Products, 2022, news item of 28 September 2022
  4. Patients return 200,000 injection pens through recycling scheme The Pharmaceutical Journal (David Lipanovic), 2023, article of 15 August 2023
  5. Novo Nordisk Opens New Insulin Formulation and Filling Facility in Russia CPHI Online, 2015, news item of 16 April 2015